Palisade Bio terminates phantom equity plan and unvested awards for executives
NegativeFinancial Markets

Palisade Bio has decided to terminate its phantom equity plan and unvested awards for its executives, a move that raises concerns about the company's financial health and governance practices. This decision could impact executive morale and retention, as these awards are often seen as incentives for performance. Stakeholders will be watching closely to see how this affects the company's future strategies and leadership stability.
— Curated by the World Pulse Now AI Editorial System